Chief coordinator & Vice Principal

Dr. Munija Pancheddula, Ph.D. (Pharmaceutics) Chief Coordinator, Research & Development Cell | Vice Principal Vision College of Pharmaceutical Sciences & Research, Hyderabad, India Introduction Dr. Munija Pancheddula is an accomplished academician, researcher, administrator, and mentor in the field of Pharmaceutics and Pharmaceutical Sciences with over thirteen years of teaching, research, and institutional leadership experience. Her professional journey reflects a sustained commitment to advancing pharmaceutical education, translational research, drug delivery innovation, and public health–oriented therapeutic development. Through an integration of scientific rigor, administrative stewardship, and student mentorship, she has consistently contributed to strengthening research ecosystems within higher education and bridging the gap between academic discovery and societal healthcare needs. Her expertise spans advanced drug delivery systems, formulation development, controlled and sustained release technologies, gastro-retentive systems, nanotechnology-based therapeutics, synbiotic and probiotic innovations, antimicrobial resistance mitigation, women’s health formulations, nutraceuticals, analytical method development, and regulatory sciences. She is particularly recognized for her interdisciplinary and problem-driven research approach that integrates pharmaceutics, biotechnology, nanoscience, and clinical translation. Academic Background Dr. Munija earned her Ph.D. in Pharmaceutics from the University College of Pharmaceutical Sciences, Kakatiya University, where her doctoral research focused on the formulation and evaluation of gastro-retentive drug delivery systems. Her work demonstrated improved oral bioavailability and therapeutic effectiveness through innovative floating and sustained-release technologies. She completed her Master of Pharmacy in Pharmaceutics with distinction, securing a high academic record and conducting research on matrix-based once-daily sustained release formulations. Her Bachelor of Pharmacy training laid a strong foundation in pharmaceutical sciences, pharmacology, pharmaceutics, and analytical chemistry. Her academic excellence from early education through postgraduate levels reflects both intellectual dedication and consistent scholarly performance. Professional Experience and Leadership With more than a decade of academic service, Dr. Munija has progressed from Assistant Professor to senior leadership roles, currently serving as Vice Principal and Chief Coordinator of the Research and Development Cell. In these capacities, she provides strategic direction for research planning, faculty development, grant acquisition, incubation initiatives, quality assurance, and innovation-driven academic culture. She has played a pivotal role in establishing and strengthening the Research & Development Cell and the IQAC framework of her institution. Her administrative responsibilities include academic planning, accreditation support, research governance, industry collaboration, and fostering a research-oriented environment for faculty and students. Her leadership philosophy is grounded in collaboration, accountability, ethical research practices, and empowerment of young investigators. She actively mentors faculty members and students to transform ideas into fundable projects, publications, and start-ups. Research Interests Dr. Munija’s research interests are diverse yet strategically interconnected, focusing on patient-centric pharmaceutical solutions and sustainable therapeutic technologies. Her major areas of interest include: Novel and advanced drug delivery systems Sustained, controlled, extended, and gastro-retentive formulations Floating microballoons and mucoadhesive systems Nanoparticles and nanomedicine-based therapeutics Synbiotic and probiotic delivery platforms Anti-microbial resistance mitigation strategies Women’s health and vaginal drug delivery technologies Nutraceuticals and plant-based bioactive formulations Clinical translation of pharmaceutical innovations Analytical method development and validation Pharmaceutical regulatory sciences and documentation AI and machine learning applications in pharmacy research Her work consistently aims to develop safe, effective, affordable, and accessible therapies that address real-world healthcare challenges. Research Contributions and Innovation A defining feature of Dr. Munija’s career is her focus on translational and socially relevant innovation. Her projects often originate from unmet clinical or public health needs and are developed into practical pharmaceutical solutions. She has conceptualized and developed several innovative research initiatives, including: Synbiotic nano-nutraceutical edible films to inhibit quorum sensing and combat antimicrobial resistance Preservative-free mucoadhesive vaginal gels for targeted therapy in dysbiotic ecosystems Integrated drug abuse detection systems for comm